Assessment of MOD-5014, a long acting FVIIA, pharmacokinetic, pharmacodynamics and correction of hemophilic coagulopathy in dogs with hemophilia a as part of the preparation for first in human study
Publication
, Conference
Hart, G; Merricks, E; Rigsbee, N; Raymer, R; Bar-Ilan, A; Binder, L; Jaron-Mendelson, M; Hoffman, M; Nichols, T
Published in: JOURNAL OF THROMBOSIS AND HAEMOSTASIS
2015
Duke Scholars
Published In
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
EISSN
1538-7836
ISSN
1538-7933
Publication Date
2015
Volume
13
Start / End Page
771 / 771
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Hart, G., Merricks, E., Rigsbee, N., Raymer, R., Bar-Ilan, A., Binder, L., … Nichols, T. (2015). Assessment of MOD-5014, a long acting FVIIA, pharmacokinetic, pharmacodynamics and correction of hemophilic coagulopathy in dogs with hemophilia a as part of the preparation for first in human study. In JOURNAL OF THROMBOSIS AND HAEMOSTASIS (Vol. 13, pp. 771–771).
Hart, G., E. Merricks, N. Rigsbee, R. Raymer, A. Bar-Ilan, L. Binder, M. Jaron-Mendelson, M. Hoffman, and T. Nichols. “Assessment of MOD-5014, a long acting FVIIA, pharmacokinetic, pharmacodynamics and correction of hemophilic coagulopathy in dogs with hemophilia a as part of the preparation for first in human study.” In JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 13:771–771, 2015.
Hart G, Merricks E, Rigsbee N, Raymer R, Bar-Ilan A, Binder L, et al. Assessment of MOD-5014, a long acting FVIIA, pharmacokinetic, pharmacodynamics and correction of hemophilic coagulopathy in dogs with hemophilia a as part of the preparation for first in human study. In: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2015. p. 771–771.
Hart, G., et al. “Assessment of MOD-5014, a long acting FVIIA, pharmacokinetic, pharmacodynamics and correction of hemophilic coagulopathy in dogs with hemophilia a as part of the preparation for first in human study.” JOURNAL OF THROMBOSIS AND HAEMOSTASIS, vol. 13, 2015, pp. 771–771.
Hart G, Merricks E, Rigsbee N, Raymer R, Bar-Ilan A, Binder L, Jaron-Mendelson M, Hoffman M, Nichols T. Assessment of MOD-5014, a long acting FVIIA, pharmacokinetic, pharmacodynamics and correction of hemophilic coagulopathy in dogs with hemophilia a as part of the preparation for first in human study. JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2015. p. 771–771.
Published In
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
EISSN
1538-7836
ISSN
1538-7933
Publication Date
2015
Volume
13
Start / End Page
771 / 771
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology